Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
James Mackay
AddedFeb 15, 2024
UpdatedMay 31, 2026
James Mackay

James Mackay

Founder, Aristea Therapeutics

CrunchbaseLinkedInThe Org

James Mackay's Career

Aristea Therapeutics
Aristea Therapeutics

San Diego, CA, US

Founder
MatriSys Bioscience
MatriSys Bioscience

Los Angeles, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

James Mackay's Career

Aristea Therapeutics
Aristea Therapeutics
$117.6M752018San Diego, CA, US
Founder

Leadership at Aristea Therapeutics

Daniel O'ConnellDaniel O'ConnellBoard Member
Ciara KennedyCiara KennedyBoard Member
Mark J GergenMark J GergenBoard Member

Similar to Aristea Therapeutics

Aria PharmaceuticalsAria PharmaceuticalsPalo Alto, CA, USPharmaceuticalsest. 2014Aria PharmaceuticalsPalo Alto, CA, US · est. 2014

Aria Pharmaceuticals: Pioneering novel therapies for complex diseases in preclinical stages.

$14.3M38
Astria TherapeuticsAstria TherapeuticsBoston, MA, USBiopharmaceuticalsest. 2008Astria TherapeuticsBoston, MA, US · est. 2008

Astria Therapeutics, Inc.: A clinical-stage biopharmaceutical company developing treatments for rare diseases and lipid disorders.

Public · $656.4M24
Argentis PharmaceuticalsArgentis PharmaceuticalsCollierville, TN, USPharmaceuticalsest. 2007Argentis PharmaceuticalsCollierville, TN, US · est. 2007

Argentis Pharmaceuticals: US-based innovator of autoimmune disease treatments.

$500k30
Exalys TherapeuticsExalys TherapeuticsSan Diego, CA, USDrugs, Therapeuticsest. 2018Exalys TherapeuticsSan Diego, CA, US · est. 2018

Exalys Therapeutics develops novel anti-inflammatory drugs, targeting diseases with limited treatments.

$15M32
MatriSys Bioscience
MatriSys Bioscience
$4.5M82015Los Angeles, CA, US
Board Member· Board

Leadership at MatriSys Bioscience

Richard GalloRichard GalloCo-Founder
Jennifer Giottonini CayerJennifer Giottonini CayerBoard Member
Philippe CalaisPhilippe CalaisCEO
Mark S. WilsonMark S. WilsonBoard Member
Magda MarquetMagda MarquetBoard Member
Gilbert KellerGilbert KellerCo-Founder

Similar to MatriSys Bioscience

Naked BiomeNaked BiomeCacheu Region, GWTherapeuticsest. 2015Naked BiomeCacheu Region, GW · est. 2015

Naked Biome: A therapeutics company advancing microbiome-based treatments for skin diseases.

$11.1M1
Petri BioPetri BioLos Angeles, CA, USTherapeuticsest. 2019Petri BioLos Angeles, CA, US · est. 2019

Petri Bio: A biotech firm innovating gut microbe-based therapeutics.

$255k3
MarvelBiomeMarvelBiomeWoburn, MA, USTherapeuticsest. 2019MarvelBiomeWoburn, MA, US · est. 2019

MarvelBiome: A biopharmaceutical company harnessing microbial power for innovative disease treatments.

$3.1M9

People Similar to James Mackay

WILL WEI CHENGWILL WEI CHENGBoard Member · DiDiBo ZhangBo ZhangCo-Founder · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailBrian KimBrian KimCo-Founder · KakaoMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoKim Beom-sooKim Beom-sooCo-Founder · KakaoBrian KimBrian KimBoard Member · KakaoDon TruesdaleDon TruesdaleCEO · Ardea PartnersJames Del FaveroJames Del FaveroCo-Founder · Ardea PartnersColin SouthColin SouthCEO · ArkeaBioChris ColeChris ColeBoard Member · Ardea PartnersNeal FineNeal FineFounder · Arcturaivan rossivan rossCo-Founder · Ardea Partners